FabRx announces launch of M3DIMAKER, first pharmaceutical 3D printer for manufacturing personalised medicines

M3DIMAKER

FabRx announces launch of M3DIMAKER

FabRx Ltd., the innovative pharmaceutical biotechnology spin-out from University College London (UCL) pioneering 3D printing of pharmaceuticals, has released the first pharmaceutical 3D printer M3DIMAKER for the manufacture of personalised medicines. FabRx is thrilled to announce that their cutting edge alternating nozzle 3D printing system, which has been tested in hospitals, pharmacies and research institutes around the world, has now been launched onto the market.

Continue reading “FabRx announces launch of M3DIMAKER, first pharmaceutical 3D printer for manufacturing personalised medicines”

Swansea University Scientists Engineer 3D Bioprinted Tissues for Pharmaceutical Research

It has been announced, that a novel application of 3D-Bioprinting living tissue models for pharmaceutical testing is being developed at Swansea University-UK. A team of scientists have begun trailing a process, which has been designed to augment the development of new drugs and treatments. Continue reading “Swansea University Scientists Engineer 3D Bioprinted Tissues for Pharmaceutical Research”